The safety and immunogenicity of a potential HIV vaccine; version 1

• Research type

  Research Study

• Full title

  A Phase 1 Open-Labelled Trial to Evaluate the Safety and Immunogenicity of CN54gp140 in HIV-Uninfected, Healthy Volunteers

• IRAS ID

  109422

• Contact name

  Sarah Fidler

• Contact email

  s.fidler@imperial.ac.uk

• Sponsor organisation

  Imperial College London and Imperial College Healthcare NHS Trust

• Eudract number

  2013-001032-22

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  13/LO/0420

• Date of REC Opinion

  16 May 2013

• REC opinion

  Further Information Favourable Opinion